Company Description

Kincellis Advanced Therapies, formed thru the merger of Kincell Bio and Cellipont Bioservices, is a U.S.-based contract development and manufacturing organization supporting advanced-therapy developers from early-stage CMC, process and analytical development through clinical supply, pivotal-stage programs and commercial supply.